HOME >> BIOLOGY >> NEWS
High blood pressure medication strategy proves effective in Hispanic women

GAINESVILLE, Fla. -- Hispanic women with hypertension and coronary artery disease respond better to drug regimens aimed at controlling high blood pressure than non-Hispanic white women, University of Florida researchers report.

A UF study described in the current issue of the Journal of Womens Health revealed that when treated with either of two commonly prescribed medication strategies, Hispanic women achieved greater blood pressure control and were half as likely as white women to suffer adverse outcomes such as heart attack, stroke or death from any cause. The findings provide new data on a population of ethnic women who have been all but absent from such research.

The study is unique in that we enrolled a substantial number of women and a substantial number of Hispanic patients from a variety of different Hispanic regions. As a result, we have data that enabled us to really fully evaluate the treatment of hypertension in this ethnically diverse group, said Rhonda Cooper-DeHoff, Pharm.D, M.S., a research assistant professor of medicine and associate director of the clinical research program in cardiovascular medicine at UFs College of Medicine.

UF researchers studied 22,500 patients enrolled in the landmark International Verapamil SR-Trandolapril study, known as INVEST, and tracked a subgroup of 5,017 Hispanic and 4,710 non-Hispanic white women who were randomly assigned to a drug strategy containing either a sustained release form of the calcium antagonist verapamil or the beta-blocker atenolol.

The INVEST study enrolled more Hispanic patients than any other hypertension trial to date, Cooper-DeHoff said, and included Hispanic participants from the mainland United States, Puerto Rico, Cuba, Mexico, Canada, Guatemala, Panama and El Salvador.

After 24 months of follow-up, researchers found that both treatment strategies worked and worked better in the Hispanic women.

Blood pressure control, defined
'"/>

Contact: Amelia Beck
ambeck@ufl.edu
352-273-5810
University of Florida
12-Jul-2007


Page: 1 2 3

Related biology news :

1. High blood pressure, low energy -- a recipe for heart failure
2. Brain blood flow gives clues to treating depression
3. Study finds gender differences in renal and other genes contributing to blood pressure
4. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
5. Research aims to identify markers for menopausal women at risk for deadly blood clot
6. Teamwork between 2 key proteins necessary for normal development and regulation of red blood cells
7. A low expression of MX2 gene exists in the white blood cells of narcoleptics
8. How a pain in the neck could be bad for your blood pressure
9. Penn researchers discover pathway that eliminates genetic defects in red blood cells
10. U-M team identifies gene that regulates blood-forming fetal stem cells
11. MicroRNA works with Ago2 protein to regulate blood cell development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/5/2019)... ... 05, 2019 , ... Catalent, the leading global provider of ... consumer health products, today announced it will present at the upcoming World Orphan ... – 14, 2019. , On Wednesday, Nov. 13 at 3:20 p.m., Philip Wills, ...
(Date:10/30/2019)... CUMBERLAND FORESIDE, Maine (PRWEB) , ... October 29, ... ... UC4 linearity and calibration verification kits, for SIEMENS ATELLICA® analyzers, Order Numbers 701sa ... GLU, K, MG, NA, PHOS, UA, UTP, and UUN. , Each VALIDATE® kit, ...
(Date:10/30/2019)... ... October 30, 2019 , ... ... and bioactivity that are encoded by the ordering of monomer residues into ... shift of the sidechain attachment to the backbone amide-nitrogen atoms. They are ...
Breaking Biology News(10 mins):
(Date:10/29/2019)... ... October 29, 2019 , ... Modality Solutions, a ... cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, November 11-12, ... The Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge technology providers, ...
(Date:10/22/2019)... ... October 22, 2019 , ... Enplug , a leading ... System into its digital signage platform. The collaboration brings one of the most ... users to leverage their existing digital signage networks to quickly disseminate critical safety ...
(Date:10/10/2019)... ... October 09, 2019 , ... The International ... Commissioner, FDA, as a newly-confirmed keynote speaker for the 2019 ISPE Annual ... USA. , Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is an internationally ...
(Date:10/8/2019)... ... 2019 , ... Erchonia Corporation, the global leader in the ... the U.S. Food and Drug Administration (FDA) has granted the company 510(k) market ... chronic neck and shoulder pain of musculoskeletal origin. , Erchonia continues to be ...
Breaking Biology Technology:
Cached News: